Literature DB >> 7941967

Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

F Gray1, F Chrétien, P Cesaro, J Chatelain, P Beaudry, J L Laplanche, J Mikol, J Bell, P Gambetti, J D Degos.   

Abstract

An 83-year-old female with no personal or familial neurological history developed progressive gait and speech disturbance and left motor deficit. She suffered intractable seizures and died 3 months after the onset of neurological signs. Neuropathology showed severe spongiosis and gliosis in the cortex and basal ganglia, and diffuse cerebral amyloid angiopathy. Immunostaining for prion protein (PrP) showed intense PrP positivity in areas of confluent spongiosis and some granular staining in astrocytes. The cortical vessel walls stained positively for beta/A4 amyloid but not for PrP amyloid. Both types of amyloid were only observed in pericapillary parenchyma, in areas with severe spongiosis. There were only a few tangles and neuritic plaques in the temporal cortex; amyloid plaques were not present either by silver stains or immunostains. There was neither arteriopathic leukoencephalopathy nor cerebral hemorrhage. Immunoblot analysis of brain extracts revealed an abnormal proteinase K-resistant isoform of PrP. Association of Creutzfeldt-Jakob disease and Cerebral amyloid angiopathy in the absence of Alzheimer changes in unusual. The association of PrP and beta/A4 amyloid deposits could have been fortuitous in an 83-year-old patient. An etiopathogenic relationship between beta/A4 amyloid deposition and PrP accumulation may also be considered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941967     DOI: 10.1007/bf00294366

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  38 in total

1.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  CNS amyloid proteins in neurodegenerative diseases.

Authors:  G W Roberts; R Lofthouse; D Allsop; M Landon; M Kidd; S B Prusiner; T J Crow
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

4.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

5.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

6.  Sträussler's disease.

Authors:  F Seitelberger
Journal:  Acta Neuropathol Suppl       Date:  1981

7.  Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides.

Authors:  K Hashimoto; T Mannen; N Nukina
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Beta PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred.

Authors:  O Bugiani; G Giaccone; L Verga; B Pollo; B Frangione; M R Farlow; F Tagliavini; B Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  1993-01       Impact factor: 3.685

9.  [Subacute spongiform encephalopathy with multiform plaque formation. "Peculiar familial-hereditary disease of CNS [spinocerebellar atrophy with dementia, plaques, and plaque-like deposits in cerebellum and cerebrum" (Gerstmann, Sträussler, Scheinker)] (author's transl)].

Authors:  J W Boellaard; W Schlote
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

View more
  5 in total

Review 1.  Alzheimer's disease and prion proteins: a meeting made in muscle.

Authors:  P Gambetti; G Perry
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

2.  Disease-associated prion protein elicits immunoglobulin M responses in vivo.

Authors:  Mourad Tayebi; Perry Enever; Zahid Sattar; John Collinge; Simon Hawke
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

3.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

4.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

5.  Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation.

Authors:  Juliette Ezpeleta; Vincent Baudouin; Zaira E Arellano-Anaya; François Boudet-Devaud; Mathéa Pietri; Anne Baudry; Anne-Marie Haeberlé; Yannick Bailly; Odile Kellermann; Jean-Marie Launay; Benoit Schneider
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.